Skip to content
Precision for Medicine
Contact Us
New Whitepaper

Beyond Geography: A Former Regulator’s Perspective on Multiregional Oncology Trials

Download Now
Boston city scape - shrinked-1

Monday, April 13 - Tuesday, April 14

CMO360 Summit 2026

Meet our Team in Boston

Oncology and rare disease development demand more than operational execution. Small patient populations, molecularly defined subgroups, evolving regulatory expectations, and  tightly integrated clinical and biomarker strategies from the outset.

Precision for Medicine is purpose-built to address these challenges. Our teams combine deep therapeutic expertise with integrated biomarker development, specialty laboratory capabilities, and global biospecimen access. This alignment enables smarter protocol design, more precise patient selection, and data packages that withstand regulatory scrutiny.

If you are refining your development strategy or preparing for a key inflection point, connect with our experts at CMO 360.

 Complete the form below to schedule a meeting with our team. 

  • Harpreet-Singh2

    Harpreet Singh, MD

    Chief Medical Officer and Former FDA Oncology Division Director

    (SizeLimitingPyList: [linkedin])
  • Noel Alaka

    Noel Alaka

    Senior Director, Business Development

    (SizeLimitingPyList: [linkedin])
  • Stephen Defusco - Headshot

    Stephen Defusco

    Director of Business and Program Development

    (SizeLimitingPyList: [linkedin])

CMO360 Summit 2026

Fairmont Copley Plaza, 138 St. James Ave Boston, MA 02116

Meet our team

Contact us using the form below. Our team will reach out to set up a meeting time at this year's CMO360 Summit.

Curated Insights

 From multiregional clinical trial design to FDA and EMA submission readiness, our integrated teams help sponsors position their therapies for global approval with confidence.  

 Explore Resources